What is the Combined histologic grading (Nottingham/Bloom-Richardson) system for breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combined Histologic Grading (Nottingham/Bloom-Richardson) System

The Nottingham modification of the Bloom-Richardson grading system (also called the Elston-Ellis modification) is the standard histologic grading method for invasive breast carcinoma that should be used in all pathology reports, as it provides critical prognostic information by evaluating three morphologic features: tubule formation, nuclear pleomorphism, and mitotic count. 1

System Components and Scoring

The grading system evaluates three distinct histologic features, each scored on a scale of 1-3 points 1, 2:

Tubule Formation (Glandular Differentiation)

  • Score 1: >75% of tumor showing tubule/gland formation
  • Score 2: 10-75% tubule formation
  • Score 3: <10% tubule formation 2

Nuclear Pleomorphism

  • Score 1: Small, regular uniform cells
  • Score 2: Moderate increase in size and variability
  • Score 3: Marked variation with large, irregular nuclei 2

Mitotic Count

  • Score 1,2, or 3: Based on number of mitoses per 10 high-power fields (specific thresholds vary by microscope field diameter and must be calibrated for each laboratory) 1, 3
  • Critical point: The mitotic count is the single most important prognostic component of the grading system and the only factor significantly associated with metastasis-free survival in multivariate analysis 3

Final Grade Assignment

The three component scores are summed to produce a total score of 3-9 points 1, 2:

  • Grade 1 (well-differentiated): 3-5 points
  • Grade 2 (moderately differentiated): 6-7 points
  • Grade 3 (poorly differentiated): 8-9 points 1, 2

Prognostic Significance

Histologic grade is one of the strongest independent prognostic factors in breast cancer, with survival worsening significantly as grade increases. 4, 2 The grade directly impacts treatment decisions and is incorporated into integrated prognostic scoring systems 1:

  • Nottingham Prognostic Index (NPI): Combines tumor size, grade, and lymph node status 1, 4
  • PREDICT score: Incorporates age, tumor stage, ER/PgR expression, HER2 status, and histological grade 1

Grade is particularly important because it helps identify patients at risk for adverse outcomes who may benefit from adjuvant therapies 5

Critical Technical Requirements

Specimen Handling

  • Optimal fixation is essential: B5 fixation provides superior nuclear morphology preservation compared to buffered formalin, resulting in better interobserver agreement (83.3% vs 73.5% complete agreement) 6
  • Proper tissue processing directly affects mitotic count accuracy, which is the most prognostic component 3

Pathologist Training and Standardization

  • Precise grading guidelines and experience significantly improve reproducibility, with kappa values of 0.73 for optimally fixed specimens when pathologists use standardized criteria 6
  • Training sets and comparison with expert consensus improve agreement rates to approximately 80% 6
  • Common pitfall: Inconsistent interpretation of cribriform or complex gland patterns can lead to systematic bias in tubule scoring 6

Mitotic Count Standardization

  • The microscope field diameter must be calibrated and documented, as mitotic count thresholds are field-size dependent 3
  • Tissue processing, microscopic observation technique, and threshold values must be well-standardized and controlled 3
  • The uneven distribution of high mitotic counts between grading systems can affect prognostic stratification (2% high mitotic index in Nottingham vs 10% in original SBR) 3

Clinical Application and Reporting

All ordinary invasive carcinomas (ductal, no special type) must be assigned a histologic grade; the specific grading system used should be stated in the pathology report. 1 Special histologic types (tubular, mucinous, papillary) are generally considered low grade by definition 1, 7

Integration with Treatment Decisions

  • Grade is essential for determining adjuvant chemotherapy benefit, particularly in ER-positive disease 1
  • When pathologists disagree on grade, consensus assessment is valuable, as patient outcomes for borderline scores (e.g., scores 5-6) fall between established grade categories 8
  • Grade 1 tumors, especially when small (≤0.5 cm), have such favorable prognosis that adjuvant systemic therapy provides minimal incremental benefit 4, 9

Quality Assurance Considerations

Histologic grading must be performed accurately on properly fixed specimens by adequately trained dedicated pathologists who diligently follow protocol methodology. 5 When adequately carried out, histologic grading remains of important prognostic value despite the availability of gene expression profiles 5

Avoid the pitfall of inconsistent grading methodology across cases or institutions, as this undermines the prognostic value and can lead to inappropriate treatment decisions 3, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Classification and grading of invasive breast carcinoma.

Verhandlungen der Deutschen Gesellschaft fur Pathologie, 2005

Guideline

Prognostic Factors in Invasive Breast Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Grading of invasive breast carcinoma: the way forward.

Virchows Archiv : an international journal of pathology, 2022

Guideline

Tubular Carcinoma Prognosis and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2000

Guideline

Treatment and Prognosis for Small Invasive Breast Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.